Related Experiment Videos

Development of hydronephrosis in spina bifida patients: predictive factors and management

P A Anderson1, A H Travers

  • 1Department of Urology, Dalhousie University, Izaak Walton Killam Children's Hospital, Halifax, Canada.

Insights

Spina bifida patients with higher spinal defects or in specific age groups face increased hydronephrosis risk. Management, often involving clean intermittent catheterisation, yielded satisfactory outcomes in 82% of cases.

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Developmental Biology

Background:

  • Spina bifida is a congenital condition impacting neural tube development, often leading to urinary tract complications.
  • Hydronephrosis, or swelling of the kidney due to urine backup, is a significant concern in children with spina bifida.

Purpose of the Study:

  • To identify predictive factors for hydronephrosis development in pediatric spina bifida patients.
  • To evaluate the effectiveness of various management strategies for hydronephrosis in this population.

Main Methods:

  • A retrospective review of 209 children diagnosed with spina bifida.
  • Analysis of renal sonography findings to detect hydronephrosis.
  • Correlation of hydronephrosis with spinal defect level and patient age.

Main Results:

  • Hydronephrosis was observed in 48% of the reviewed cases.
  • Higher spinal defect levels and specific age periods (infancy and teenage years with CIC) were identified as significant risk factors.
  • Clean intermittent catheterisation (CIC), with or without anticholinergic medication, was the primary treatment, achieving satisfactory outcomes in 82% of treated patients.

Conclusions:

  • Renal sonography is an effective screening tool for detecting upper urinary tract changes in spina bifida.
  • Early identification and management of risk factors, particularly spinal level and age, are crucial for preventing or treating hydronephrosis.
  • Multimodal treatment approaches, including CIC, are effective in managing hydronephrosis in spina bifida patients.

Related Concept Videos